The following valvular disorders are considered here in the context of competitive athletes: mitral stenosis (MS), mitral regurgitation (MR), aortic stenosis (AS), aortic regurgitation (AR), tricuspid regurgitation (TR), tricuspid stenosis, and multivalvular disease. Recommendations are also provided for patients who have undergone valve repair or replacement.
The diagnosis of valvular heart disease usually can be made on the basis of the characteristic murmurs and associated findings on physical examination. Estimation of the severity of valvular disease is more difficult. In athletes, where secondary gain in denying symptoms is likely, the history may be unreliable. In truly asymptomatic patients, severity can usually be determined from the physical examination and Doppler echocardiography. Additional testing is often not necessary, but the electrocardiogram (ECG) and chest radiograph can also aid in assessing severity, and radionuclide angiography or cardiac magnetic resonance are helpful in assessing left ventricular (LV) function when the echocardiogram is of suboptimal quality.
Doppler echocardiography is the most important diagnostic test for valvular heart disease and is generally reliable in distinguishing the severity of the lesion and assessing hemodynamics and ventricular compensation. Although very sensitive in identifying regurgitant jets, quantitation can be more difficult. Recent guidelines have provided recommendations for quantifying valvular regurgitation (1) . Only rarely are cardiac catheterization and angiography necessary to determine the hemodynamic severity of valvular lesions.
Valvular regurgitation is frequently detected in normal subjects, including those without murmurs. With pulsed Doppler echocardiography, TR has been reported in 24% to 96% of normal subjects, MR in 10% to 40%, pulmonic regurgitation in 18% to 92%, and AR in 0% to 33% (2, 3) . In athletes, the prevalence of valvular regurgitation detected by Doppler is even higher, with at least one regurgitant jet found in greater than 90% of subjects and triple-valve regurgitation in 20% (4) . The vast majority of these jets represents a trivial regurgitant volume and is of no clinical significance.
Although considerable information exists concerning the natural history, development of symptoms, importance of LV function, and indications for surgical or catheter-based intervention in patients with valvular heart disease (5) , there are few data with regard to the rate of progression of the valvular disease (especially in those exercising vigorously) or factors that influence the rate of progression. The rate of progression of aortic stenosis is highly variable among individuals and difficult to predict (6) . Chronic MR may increase in severity with time but is more likely to do so in patients who experience a new chordal rupture and flail mitral leaflet (7) . Little is known about the influence of strenuous exertion on the progression of ventricular dysfunction, especially when that exertion is periodic in nature. When valvular disease coexists with another cardiovascular abnormality, such as arrhythmias or coronary artery disease (CAD), recommendations with regard to eligibility for sports should be based on the most restrictive of these guidelines.
The present recommendations with regard to the permitted level of athletic activity are offered only as guidelines. Physicians with knowledge of an individual athlete, including the severity of the lesion and the physiological and psychological response to competition, may liberalize these recommendations in selected instances. The recommendations are for those athletes who are asymptomatic, as symptoms will prevent vigorous exercise in most subjects and, in most circumstances, symptoms represent an indication for valve replacement or repair (5) . In situations in which the history may be unreliable (e.g., when secondary gain in denying symptoms is likely), exercise tolerance testing is useful in confirming normal effort tolerance and suitability for the proposed athletic activity.
MITRAL STENOSIS
The etiology of MS is almost always rheumatic. Most patients with significant MS will be sufficiently symptomatic that participation in competitive sports is not an issue, but patients with mild-to-moderate MS may be asymptomatic even with strenuous exercise. Although MS rarely causes sudden death, exercise (with an increase in heart rate and cardiac output) can cause sudden marked increases in pulmonary capillary and pulmonary artery pressures, at times resulting in sudden acute pulmonary edema (8) . Furthermore, the long-term effect of repeated exertion-related increases in pulmonary artery wedge and pulmonary artery pressures on the lungs or right ventricle is unknown. The effect of even periodic strenuous exercise on the likelihood of developing atrial fibrillation is also not known. When atrial fibrillation occurs, even patients with mild MS must be anticoagulated. The aforementioned considerations must be understood by the patient and the family in considering participation in strenuous competitive activity. Another problem associated with MS is systemic embolization, occurring most commonly in the presence of atrial fibrillation, but there is no evidence that this potential complication is provoked by strenuous exercise.
Evaluation. Clues regarding the hemodynamic severity of MS may often be obtained from the history, physical examination, ECG, and chest radiograph, but accurate noninvasive assessment of severity requires two-dimensional and Doppler echocardiography (9) . In patients with MS and minimal or no symptoms who wish to engage in competitive sports, exercise stress testing should be performed to at least the level of activity approximating the exercise demands of the sport, particularly when there is a question as to the severity of the MS. In addition, pulmonary artery systolic pressure during exercise can be estimated noninvasively by Doppler echocardiography and may be helpful in making a decision as to how much activity is safe, even if the severity of MS in an individual patient is estimated to be only mild (5) . If this is not practical or possible, then right heart catheterization with exercise can be performed to measure the pulmonary capillary wedge pressure and pulmonary artery pressure.
Hemodynamic severity of MS can be categorized as follows: mild ϭ mitral valve area greater than 1.5 cm 2 , exercise pulmonary artery wedge pressure less than or equal to 20 mm Hg, or rest pulmonary artery systolic pressure less than 35 mm Hg; moderate ϭ mitral valve area 1.0 to 1.5 cm 2 , exercise pulmonary artery wedge pressure less than or equal to 25 mm Hg, or rest pulmonary artery systolic pressure less than or equal to 50 mm Hg; severe ϭ mitral valve area less than 1.0 cm 2 , exercise pulmonary artery wedge pressure greater than 25 mm Hg, or rest pulmonary systolic pressure greater than 50 mm Hg. (10) . The severity of chronic MR can be adequately judged by noninvasive techniques, principally two-dimensional and Doppler echocardiography. The larger the jet area, and the wider the jet at its origin above the valve, the more severe the regurgitation. The entry of the jet into the atrial appendage or pulmonary vein or systolic reversal of the flow in pulmonary veins are all indicators of severity. Various measures of the severity of MR have been described (1, 11) . In some patients with eccentric jets or those impinging on the atrial wall, the assessment may be difficult (1). Generally, the LV diastolic volume reflects the severity of chronic MR. However, it should be noted that the upper limit of normal LV size is increased in the healthy, highly trained athlete. In a series of elite athletes, echocardiographic LV end-diastolic dimensions as high as 66 mm were recorded in women (mean, 48 mm) and up to 70 mm in men (mean, 55 mm) (12) . LV end-diastolic dimensions greater than or equal to 55 mm were observed in 45% of participants and greater than 60 mm in 14% of participants. Therefore, assessment of LV enlargement in a highly trained athlete with known or suspected valvular heart disease must take this issue into consideration. Hence, for purposes of this discussion, an LV end-diastolic dimension greater than 60 mm is considered likely to represent the effects of LV volume overload due to valvular disease and not per se to physiologically based exercise training.
Recommendations
Patients with chronic MR should be followed longitudinally with serial echocardiograms (5) . A decrease in ejection fraction and/or increase in end-systolic volume with time is a helpful marker of declining LV function and an indication of having reached the limits of cardiac compensation.
Effects of exercise.
In general, exercise produces no significant change or a mild decrease in the regurgitant fraction because of reduced systemic vascular resistance. However, patients with elevation of heart rate (increased systolic ejection time per min) or blood pressure with exercise may manifest marked increases in regurgitant volume and pulmonary capillary pressures. Hence, static exercise that increases arterial pressure is potentially deleterious. Ejection fraction usually does not change or decreases slightly with exercise, although the ejection fraction response may be completely normal in young, asymptomatic subjects.
The etiology of MR may be important in making recommendations concerning heavy physical activity. In patients with MR secondary to previous infective endocarditis or ruptured chordae, the valve tissues theoretically could be further damaged or torn by marked sustained increases in LV systolic pressure. 
Recommendations

AORTIC STENOSIS
The diagnosis of AS is established by the characteristic physical findings and two-dimensional and Doppler echocardiography. The three most common etiologies are: 1) rheumatic, 2) congenital, and 3) calcific or degenerative. The majority of young adults with AS participating in competitive athletics have congenital lesions. Evaluation. Continuous-wave Doppler echocardiography can reliably estimate the severity of AS, especially in the presence of normal cardiac output, which is the case in the great majority of those engaging in competitive sports (13) . Symptoms of dyspnea, syncope, or angina pectoris occur late in the course of AS (14), and the likelihood of sudden death increases significantly with the onset of symptoms.
Because even transient symptoms are so important in marking the onset of increased risk of sudden death, the physician must be aware that dyspnea, near-syncope, and even syncope are likely to be unreported in competitive athletes. Although sudden death is more frequent in symptomatic patients with severe AS, it may also occur in completely asymptomatic patients (15) . When doubt persists with regard to the severity of AS after Doppler study, or if a patient with mild-to-moderate AS has symptoms, cardiac catheterization should be performed. Sudden death is rare with mild AS.
Athletes with a history of syncope, even with mild AS, should be carefully evaluated by a cardiologist. This should include assessment of arrhythmias with exercise. Syncope should be regarded as a possible surrogate for spontaneously aborted sudden death and should be thoroughly investigated (see Task Force 7: Arrhythmias).
Severity of AS measured by continuous-wave Doppler echocardiography (or in those instances previously noted by cardiac catheterization) is categorized as follows with respect to the calculated aortic valve area: mild ϭ greater than 1.5 cm 2 ; moderate ϭ 1.0 to 1.5 cm 2 ; and severe ϭ less than or equal to 1.0 cm 2 (5). This translates roughly (assuming that athletes have normal cardiac output) to the estimated mean aortic valve pressure gradient as follows: mild ϭ less than 25 mm Hg; moderate ϭ 25 to 40 mm Hg; and severe ϭ greater than 40 mm Hg (5).
Because AS is often progressive, periodic re-evaluation at least yearly is necessary and should be performed by a physician with expertise in cardiology. This reassessment includes physical examination and Doppler echocardiography, but may require cardiac catheterization in selected patients as previously noted. In addition, Holter monitoring with intense exercise resembling competition is recommended to detect ventricular arrhythmias in patients with AS who wish to participate in competitive athletics.
In patients with AS, a markedly elevated cardiac output or peripheral vascular resistance for sustained periods of time could result in an exaggerated valvular gradient and a marked increase in LV systolic pressure. Given these precautions, the following recommendations can be made. 
Recommendations:
Athletes with mild AS can participate in all compet
AORTIC REGURGITATION
Aortic regurgitation has multiple etiologies, as any disease affecting the aortic valve, annulus, or proximal ascending aorta can result in AR. The common etiologies are: 1) congenital bicuspid aortic valve; 2) rheumatic heart disease; 3) infective endocarditis; and 4) aortic root diseases, including Marfan syndrome, ascending aortic aneurysm, aortic dissection, systemic hypertension, and rheumatoid spondylitis. Aortic regurgitation increases LV diastolic volume and stroke volume, which may ultimately lead to LV systolic dysfunction (10) . In addition, myocardial oxygen supply/ demand imbalance may develop because of the increased wall stress, LV hypertrophy, and reduced diastolic blood pressure (reduced coronary perfusion pressure).
Patients with severe AR may remain asymptomatic and athletic for many years, but angina pectoris, syncope, and ventricular arrhythmias ultimately may appear. Sudden death is rare among asymptomatic patients (less than 0.2% per year [5] ) but can occur. Evaluation. The hemodynamic severity of AR can be assessed noninvasively by physical examination (the severity being reflected by the degree of LV dilation and the peripheral signs of AR), chest radiography, and echocardiography. As noted previously, the upper limit of normal LV end-diastolic size is increased in the healthy, highly trained athlete (12) , and this may well affect assessment of LV enlargement in the setting of AR.
Because of the importance of assessing LV function and the size of the aortic root and proximal ascending aorta in determining the etiology of AR, with resulting implications for athletic participation, evaluation by echocardiography is essential. Doppler echocardiography is very sensitive in detecting any degree of AR. Similar to MR, the greatest difficulty arises in differentiating moderate and severe AR. Qualitatively, the width of the regurgitant jet and the proportion of the LV outflow tract occupied by the jet are related to the severity of the AR, as is the slope velocity profile of the diastolic jet. The regurgitant volume can also be measured quantitatively by Doppler methods (1) .
The LV function should be assessed serially by twodimensional echocardiography (5) . Radionuclide angiography or cardiac magnetic resonance may be helpful if echocardiograms are of suboptimal quality. Exercise testing can be useful in assessing exercise capacity, especially in those patients having nonspecific or mild symptoms, and it is recommended that testing be performed to at least the level of exertion required by the proposed competitive sport.
Holter monitoring with intense exercise resembling competition is recommended to detect ventricular arrhythmias in patients who wish to participate in competitive athletics. Effects of exercise. With exercise, regurgitant volume decreases because of the decrease in peripheral vascular resistance that reduces diastolic blood pressure and the decrease in diastolic filling period that accompanies the increase in heart rate (16) . Because of these changes in preload and afterload, the failure of the ejection fraction to increase with exercise is of uncertain significance, and there are insufficient data with which to use this finding in formulating recommendations regarding participation in competitive athletics. There are also no data to define whether severe increases in physical activity permanently affect the function of the left ventricle.
For purposes of the following recommendations, hemodynamic severity of AR is graded as follows: mild ϭ absent to slight peripheral signs of AR, normal LV size; moderate ϭ peripheral signs of AR with mild-to-moderate increases in LV size with normal systolic function; and severe ϭ peripheral signs of AR with severe LV enlargement and/or LV systolic dysfunction. 
Recommendations
BICUSPID AORTIC VALVES WITH AORTIC ROOT DILATATION
There is growing awareness that many patients with bicuspid aortic valves have disorders of vascular connective tissue, involving loss of elastic tissue, that may result in aortic root dilatation even in the absence of hemodynamically significant AS or AR (17, 18) . These patients have a risk of aortic dissection; surgery to repair the aorta has been recommended for those patients with greatly enlarged aortic roots (5, 18) . Recommendations for athletic participation in patients with bicuspid valve disease and associated aortic root dilatation are based on limited data, but with the understanding that aortic dissection can occur in some patients with aortic root diameters less than 50 mm. The recommendations that follow are for patients with bicuspid valves and associated aortic root enlargement. If such patients also have significant AS or AR, these recommendations should be considered in concert with those discussed in the present Task Force for patients with AS or AR. The following recommendations do not pertain to patients with Marfan syndrome, which are discussed in Task Force 4.
Recommendations:
1 
TRICUSPID REGURGITATION
Tricuspid regurgitation is most often secondary to right ventricular (RV) dilation and failure due to pulmonary or RV hypertension. Other etiologies that may affect athletes include rheumatic heart disease, tricuspid valve prolapse, infective endocarditis, congenital anomalies such as Ebstein's anomaly, and the sequelae of surgery for congenital heart disease leaving the patient with RV dilatation. Recommendations here with respect to athletes are for those with primary TR. Primary TR leads to RV volume overload with the risk of subsequent RV failure as well as increased systemic venous pressure and its consequences. Severity of TR and estimation of right atrial and RV pressures can be determined noninvasively from physical examination, chest radiograph, and Doppler echocardiography. Occasionally, right-heart catheterization is necessary when these measures cannot be determined noninvasively. There is no evidence that the athlete with isolated primary TR is placed in jeopardy by engaging in heavy physical exertion. 
Recommendation
TRICUSPID STENOSIS
Tricuspid stenosis is for the most part caused by rheumatic heart disease and is nearly always associated with MS. In that instance, the patient should be judged according to the severity of the MS. Isolated tricuspid stenosis is rare. Such patients should undergo exercise testing at least to the level anticipated in their sport. If asymptomatic, athletes may compete in all competitive activities.
MULTIVALVULAR DISEASE
Multivalvular disease occurs in the context of rheumatic heart disease, myxomatous valvular disease, and infective endocarditis. The lesions can be diagnosed by physical examination and Doppler echocardiography. The relative contribution of each of the lesions may be difficult to assess noninvasively, and cardiac catheterization and angiocardiography are frequently necessary to resolve these distinctions.
Recommendation:
1. Multiple lesions of moderate severity may have additive physiologic effects. In general, athletes with significant multiple valvular disease should not participate in any competitive sports.
PROSTHETIC HEART VALVES
Several general comments apply to all patients who have undergone valve replacement. First, although most patients improve after valve replacement and many become asymptomatic, the long-term mortality after operation is greater than that of a normal population of similar age. Second, a transvalvular gradient of varying severity is present in most patients after valve replacement (5, 19) . Third, although hemodynamic variables at rest may be essentially normal after valve replacement, many patients have an abnormal response to exercise (20) . Finally, after valve replacement (with few exceptions) patients with mechanical prostheses require anticoagulant agents, and those with bioprosthetic valves in sinus rhythm usually do not. In assessing the athlete's capacity for physical activity, exercise stress testing to at least the level of activity performed in the competitive sport is valuable.
Effects of exercise.
There are insufficient data to determine whether vigorous repetitive exercise after valve replacement has any long-lasting effect on ventricular or prosthetic valve function. The patient should be made aware of these deficiencies in our knowledge before deciding whether to participate in competitive athletics. Because mechanical and most tissue valves have reduced effective valve areas, they perform best at normal heart rates. Therefore, a sustained heart rate greater than 120 beats/min might result in elevated valve gradients and cardiac outputs that are less than normally expected.
Recommendations:
